Profusa (NASDAQ: PFSA) Moves Listing to Nasdaq Capital Market
Key Developments Profusa (NASDAQ: PFSA), a company advancing digital health technology for continuous biochemical monitoring, has announced a significant update regarding its stock listing. As of May 15, 2026, Profusa’s shares will be officially transferred to trading on The Nasdaq Capital Market. This move to The Nasdaq Capital Market reflects the company’s progress and growth in the digital health sector, positioning it within a respected marketplace that may provide enhanced…









